Top Section/Ad
Top Section/Ad
Most recent
French biotech seeks to accelerate cancer vaccine program
Payment processor's shares dropped to new low on Thursday
More articles/Ad
More articles/Ad
More articles
-
Rights issue was oversubscribed despite a volatile backdrop -
Holiday company's biggest shareholder cannot participate due to EU sanctions
-
Rights issue volumes have surged in Europe this week as bankers expect more activity
-
Bankers expect more acquisition-related capital increases once volatility subsides
-
Ukraine war has turbocharged Europe’s need to invest in renewable energy
-
German-based travel company could launch deal within weeks, but without major shareholder
